Five-day courses of irinotecan as palliative therapy for patients with neuroblastoma Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents, Phytogenic
  • Camptothecin
  • Nervous System Neoplasms
  • Neuroblastoma
  • Palliative Care

abstract

  • In heavily treated patients, the regimen studied was well tolerated, allowed patients to continue most normal life activities, and produced anti-NB effects. Its modest toxicity supported use with other antitumor agents.

publication date

  • February 15, 2005

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.20846

PubMed ID

  • 15637685

Additional Document Info

start page

  • 858

end page

  • 62

volume

  • 103

number

  • 4